MATTHEW LOUDON: Open Payments
NPI 1922498781 · WASILLA, AK. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,470 in 44 payments from 11 companies in 2025. Trend: 2023 $685 · 2024 $900 · 2025 $3,470
Travel & lodging: $2,270Food & beverage: $1,136Education: $65
| Company | Payments | Amount |
|---|---|---|
| Insulet Corporation | 15 | $2,662 |
| SANOFI-AVENTIS U.S. LLC | 7 | $288 |
| Amgen Inc. | 8 | $187 |
| Novo Nordisk Inc | 5 | $130 |
| Novartis Pharmaceuticals Corporation | 2 | $50 |
| Abbott Laboratories | 2 | $36 |
| Corcept Therapeutics | 1 | $35 |
| Xeris Pharmaceuticals, Inc. | 1 | $25 |
| Lilly USA, LLC | 1 | $21 |
| ABBVIE INC. | 1 | $18 |
Products named: OMNIPOD, TZIELD, REPATHA, Ozempic, EVENITY, LEQVIO, FREESTYLE LIBRE 3, Korlym.
Industry payments across AK — which companies pay providers there.
